| Dr Naveen Premnath, MD | |
|
420 Delaware St. Se,, Mmc 480, Minneapolis, MN 55455 | |
| (612) 626-2446 | |
| Not Available |
| Full Name | Dr Naveen Premnath |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 420 Delaware St. Se,, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205380375 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 73943 (Minnesota) | Primary |
| Entity Name | University Of Minnesota Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477598118 PECOS PAC ID: 9830001189 Enrollment ID: O20031104000532 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
President Bush on Tuesday said he would veto a more than $700 billion package under consideration by Democrats that includes the fiscal year 2008 Defense (HR 3222), Labor-HHS-Education (HR 3043) and Military Construction-Veterans Affairs (HR 2642) appropriations bills, The Hill reports (Soraghan et al., The Hill, 10/31).
Partnering in an innovative health initiative, the City Produce Project and the participating churches of the Actions Connected to Spirituality Forming Alliances in Transforming Health (A.C.T.S. of F.A.I.T.H.) are calling for more public and private partnerships to create programming that directly addresses obesity and its associated co-morbidities in underserved communities.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
› Verified 2 days ago
| Entity Name | Healtheast Medical Research Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
President Bush on Tuesday said he would veto a more than $700 billion package under consideration by Democrats that includes the fiscal year 2008 Defense (HR 3222), Labor-HHS-Education (HR 3043) and Military Construction-Veterans Affairs (HR 2642) appropriations bills, The Hill reports (Soraghan et al., The Hill, 10/31).
Partnering in an innovative health initiative, the City Produce Project and the participating churches of the Actions Connected to Spirituality Forming Alliances in Transforming Health (A.C.T.S. of F.A.I.T.H.) are calling for more public and private partnerships to create programming that directly addresses obesity and its associated co-morbidities in underserved communities.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
› Verified 2 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
President Bush on Tuesday said he would veto a more than $700 billion package under consideration by Democrats that includes the fiscal year 2008 Defense (HR 3222), Labor-HHS-Education (HR 3043) and Military Construction-Veterans Affairs (HR 2642) appropriations bills, The Hill reports (Soraghan et al., The Hill, 10/31).
Partnering in an innovative health initiative, the City Produce Project and the participating churches of the Actions Connected to Spirituality Forming Alliances in Transforming Health (A.C.T.S. of F.A.I.T.H.) are calling for more public and private partnerships to create programming that directly addresses obesity and its associated co-morbidities in underserved communities.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
› Verified 2 days ago
| Entity Name | University Of Minnesota Health Clinics And Surgery Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053795187 PECOS PAC ID: 9133423304 Enrollment ID: O20160209000524 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
President Bush on Tuesday said he would veto a more than $700 billion package under consideration by Democrats that includes the fiscal year 2008 Defense (HR 3222), Labor-HHS-Education (HR 3043) and Military Construction-Veterans Affairs (HR 2642) appropriations bills, The Hill reports (Soraghan et al., The Hill, 10/31).
Partnering in an innovative health initiative, the City Produce Project and the participating churches of the Actions Connected to Spirituality Forming Alliances in Transforming Health (A.C.T.S. of F.A.I.T.H.) are calling for more public and private partnerships to create programming that directly addresses obesity and its associated co-morbidities in underserved communities.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Naveen Premnath, MD 420 Delaware St. Se,, Mmc 480, Minneapolis, MN 55455 Ph: (612) 626-2446 | Dr Naveen Premnath, MD 420 Delaware St. Se,, Mmc 480, Minneapolis, MN 55455 Ph: (612) 626-2446 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
President Bush on Tuesday said he would veto a more than $700 billion package under consideration by Democrats that includes the fiscal year 2008 Defense (HR 3222), Labor-HHS-Education (HR 3043) and Military Construction-Veterans Affairs (HR 2642) appropriations bills, The Hill reports (Soraghan et al., The Hill, 10/31).
Partnering in an innovative health initiative, the City Produce Project and the participating churches of the Actions Connected to Spirituality Forming Alliances in Transforming Health (A.C.T.S. of F.A.I.T.H.) are calling for more public and private partnerships to create programming that directly addresses obesity and its associated co-morbidities in underserved communities.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
› Verified 2 days ago
Pascal Frino, M.D Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Dr, Minneapolis, MN 55417 Phone: 612-467-3183 | |
Dr. Ronald Alexander Reilkoff, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 | |
Eugenia Shmidt, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 507-284-2511 | |
Daniel Tesfaye Kebed, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 Fax: 612-273-4098 | |
Tenzin Yangchen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2925 Chicago Ave, Minneapolis, MN 55407 Phone: 612-863-4000 Fax: 763-236-3026 | |
Shelley M Lennox, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 920 E 28th St, Suite 700, Minneapolis, MN 55407 Phone: 612-863-9062 Fax: 612-863-9252 | |
Dr. Markus Meyer, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 |